Immune & Antioxidant Research

Thymosin Alpha-1 10mg

Thymosin Alpha-1 10mg

£35.00

Thymosin Alpha 1 (Tα1) 10mg per vial — high-purity lyophilized research peptide from Core Research. Supplied for laboratory research. For Research Purposes Only. Not for human or veterinary use.

 

 

Description

Thymosin Alpha 1 (Tα1) 10mg — Product Identity and Format

Thymosin Alpha 1 (Tα1) 10mg is a research-grade lyophilised preparation of Thymosin Alpha 1, a 28-amino-acid peptide originally isolated from thymosin fraction 5 of bovine thymus by Allan Goldstein and colleagues in 1977. The sequence of Tα1 is Ac-Ser-Asp-Ala-Ala-Val-Asp-Thr-Ser-Ser-Glu-Ile-Thr-Thr-Lys-Asp-Leu-Lys-Glu-Lys-Lys-Glu-Val-Val-Glu-Glu-Ala-Glu-Asn-OH, incorporating an N-terminal acetylation that is essential for biological activity. Each 10mg vial supplied by Core Research contains lyophilised Tα1 acetate salt, verified by RP-HPLC to a minimum purity of ≥99.0%, with molecular identity confirmed by ESI-MS.

Compound Identity Matrix

Attribute Value Specification
Common Name Thymosin Alpha 1 (Tα1); Thymalfasin 28-amino-acid thymic immunomodulatory peptide
Residue Count 28 amino acids N-terminal acetylation essential for activity
CAS Number 62304-98-7 Thymosin Alpha 1 (human)
Molecular Formula C129H215N33O55 Free base (N-terminal acetylated)
Molecular Weight 3,108.28 Da Free base (monoisotopic)
Primary Targets TLR2, TLR9; T-cell receptors Innate and adaptive immune system modulation
Physical Form White lyophilised powder Acetate salt; hygroscopic
Quantity per Vial 10 mg Research-grade lyophilised preparation
Purity (RP-HPLC) ≥99.0% C18 column, UV 220 nm
Identity Confirmation ESI-MS ±0.1 Da of theoretical MW

Analytical Specification & Release Testing

Every batch of Thymosin Alpha 1 10mg supplied by Core Research is manufactured under GMP-aligned conditions and subjected to a comprehensive analytical release protocol. Purity is determined by RP-HPLC (C18 column, UV 220 nm) confirming ≥99.0% purity with a maximum single impurity of ≤0.5%. Molecular identity is confirmed by ESI-MS with the observed [M+nH]ⁿ⁺ ion series matched against the theoretical mass of Tα1 (MW 3,108.28 Da) to within ±0.1 Da. Endotoxin content is confirmed at <1.0 EU/mg by LAL kinetic turbidimetric assay. Residual moisture is confirmed at <5.0% w/w by Karl Fischer titration.

Test Parameter Method Specification Typical Result
Purity (RP-HPLC) C18 column, UV 220 nm ≥99.0% ≥99.5%
Identity (ESI-MS) Electrospray ionisation MS ±0.1 Da of theoretical MW Conforms
Endotoxin (LAL) Kinetic turbidimetric LAL <1.0 EU/mg <0.5 EU/mg
Residual Moisture Karl Fischer titration <5.0% w/w <3.0% w/w
Appearance Visual inspection White lyophilised powder Conforms

Storage, Stability & Handling

Condition Specification Notes
Long-term storage (lyophilised) −20°C Stable for ≥24 months from manufacture date
Short-term storage (lyophilised) 2–8°C Acceptable for up to 4 weeks; desiccated
Reconstituted solution 2–8°C, use within 14 days Aliquot and freeze at −80°C for extended storage
Freeze-thaw cycles Minimise; ≤3 cycles recommended Aliquot prior to freezing
Humidity Low humidity environment Hygroscopic peptide; desiccant recommended

Frequently Asked Questions

What is the molecular weight of Thymosin Alpha 1?
The molecular weight of Thymosin Alpha 1 is 3,108.28 Da (free base, N-terminal acetylated). The molecular formula is C129H215N33O55 and the CAS number is 62304-98-7. Tα1 is a 28-amino-acid peptide with an N-terminal acetylation that is essential for biological activity.

Is a Certificate of Analysis available?
Yes. Batch-specific CoA documents — including annotated HPLC chromatograms and MS data — are available through the Core Research CoA Portal and are included with each order.

Related Research Guides

Related Compound

Ara-290 10mg — EPO Receptor Research

 

Related Compound

 

Quality

Certificate of Analysis Portal

 

Category

Immune Research Catalogue

 

Research context

The published literature on this material is summarised in the laboratory guides linked below. This record describes the material as supplied: identity, format, analytics, storage and documentation. It does not describe effects, and none should be inferred from the catalogue category.

For Research Use Only

Thymosin Alpha 1 is supplied exclusively for in vitro laboratory and pre-clinical research. Not for human or veterinary use. No dosing, reconstitution, or administration guidance is provided. Purchase confirms the buyer is a qualified researcher.

Additional information

Format

Vial

Strength

10mg